Inadvertently Developed Ventricular Fibrillation during Electrophysiologic Study and Catheter Ablation: Incidence, Cause, and Prognosis

Background and Objectives Ventricular fibrillation (VF) can inadvertently occur during electrophysiologic study (EPS) or catheter ablation. We investigated the incidence, cause, and progress of inadvertently developed VF during EPS and catheter ablation. Subjects and Methods We reviewed patients who had developed inadvertent VF during EPS or catheter ablation. Patients who developed VF during programmed ventricular stimulation to induce ventricular tachycardia or VF were excluded. Results Inadvertent VF developed in 11 patients (46.7±9.3 years old) among 2624 patients (0.42%); during catheter ablation for atrial fibrillation (AF) in nine patients, frequent ventricular premature beats (VPBs) in one, and Wolff-Parkinson-White (WPW) syndrome were observed in one. VF was induced after internal cardioversion in six AF patients due to incorrect R-wave synchronization of a direct current shock. Two AF patients showed spontaneous VF induction during isoproterenol infusion while looking for AF triggering foci. The remaining AF patient developed VF after rapid atrial pacing to induce AF, but the catheter was accidentally moved to the right ventricular (RV) apex. A patient with VPB ablation spontaneously developed VF during isoproterenol infusion. The focus of VPB was in the RV outflow tract and successfully ablated. A patient with WPW syndrome developed VF after rapid RV pacing with a cycle length of 240 ms. Single high energy (biphasic 150-200 J) external defibrillation was successful in all patients, except in two, who spontaneously terminated VF. The procedure was uneventfully completed in all patients. At a mean follow-up period of 17.4±15.5 months, no patient presented with ventricular arrhythmia. Conclusion Although rare, inadvertent VF can develop during EPS or catheter ablation. Special caution is required to avoid incidental VF during internal cardioversion, especially under isoproterenol infusion.

[1]  W. Shimizu,et al.  Electrophysiologic characteristics andimplications of induced ventricular fibrillationin symptomatic patients with brugada syndrome , 2002 .

[2]  K. Kettering,et al.  Kammerflimmern bei intraatrialer Kardioversion von Vorhofflimmern , 2000, Zeitschrift für Kardiologie.

[3]  H. Barold,et al.  Ventricular Fibrillation Resulting from Synchronized Internal Atrial Defibrillation in a Patient with Ventricular Preexcitation , 1997, Journal of cardiovascular electrophysiology.

[4]  Barold Hs,et al.  Ventricular fibrillation resulting from synchronized internal atrial defibrillation in a patient with ventricular preexcitation. , 1997 .

[5]  A. Camm,et al.  Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. , 1995, Journal of the American College of Cardiology.

[6]  R. Ideker,et al.  Internal Cardioversion of Atrial Fibrillation in Sheep , 1993, Circulation.

[7]  M. Scheinman,et al.  Emergency intracardiac defibrillation for refractory ventricular fibrillation during routine electrophysiologic study. , 1991, Journal of the American College of Cardiology.

[8]  R. Winkle,et al.  Effect of duration of ventricular fibrillation on defibrillation efficacy in humans. , 1990, Circulation.

[9]  P. Kowey,et al.  Effect of Antiarrhythmic Drugs on Defibrillation Threshold: Case Report of an Adverse Effect of Mexiletine and Review of the Literature , 1988, Pacing and clinical electrophysiology : PACE.

[10]  T. Guarnieri,et al.  Success of chronic defibrillation and the role of antiarrhythmic drugs with the automatic implantable cardioverter/defibrillator. , 1987, The American journal of cardiology.

[11]  H. Halperin,et al.  Relationship between canine transthoracic impedance and defibrillation threshold. Evidence for current-based defibrillation. , 1987, The Journal of clinical investigation.

[12]  L. Horowitz,et al.  Risks and complications of clinical cardiac electrophysiologic studies: a prospective analysis of 1,000 consecutive patients. , 1987, Journal of the American College of Cardiology.

[13]  R. Rosenthal,et al.  Open-chest cardiopulmonary resuscitation. , 1986, The American journal of emergency medicine.

[14]  A. Sharma,et al.  Effect of adrenergic stimulation and blockade on ventricular defibrillation in the rat. , 1983, The Journal of pharmacology and experimental therapeutics.

[15]  F. Morady,et al.  Invasive cardiac electrophysiologic testing: the current state of the art. , 1983, Circulation.

[16]  B. Surawicz.  Intracardiac extrastimulation studies: How to? Where? By whom? , 1982, Circulation.

[17]  L. Opie,et al.  Biochemical aspects of arrhythmogenesis and ventricular fibrillation. , 1979, The American journal of cardiology.

[18]  W. Shimizu,et al.  Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome. , 2002, Journal of the American College of Cardiology.

[19]  C. Mewis,et al.  [Ventricular fibrillation in intra-atrial cardioversion of atrial fibrillation]. , 2000, Zeitschrift fur Kardiologie.

[20]  C. Babbs,et al.  Effects of myocardial infarction on catheter defibrillation threshold. , 1983, Medical instrumentation.

[21]  P. Denes,et al.  Clinical electrophysiology--a decade of progress. , 1983, Journal of the American College of Cardiology.